Related references
Note: Only part of the references are listed.Quantitative Imaging of the Hypoxia-Related Marker CAIX in Head and Neck Squamous Cell Carcinoma Xenograft Models
Fokko J. Huizing et al.
MOLECULAR PHARMACEUTICS (2019)
CAIX-targeting radiotracers for hypoxia imaging in head and neck cancer models
Fokko J. Huizing et al.
SCIENTIFIC REPORTS (2019)
Preclinical validation of In-111-girentuxiniab-F(ab')(2) as a tracer to image hypoxia related marker CAIX expression in head and neck cancer xenografts
Fokko J. Huizing et al.
RADIOTHERAPY AND ONCOLOGY (2017)
Antibody or Antibody Fragments: Implications for Molecular Imaging and Targeted Therapy of Solid Tumors
Katerina T. Xenaki et al.
FRONTIERS IN IMMUNOLOGY (2017)
Evofosfamide, a new horizon in the treatment of pancreatic cancer
Mohsen Pourmorteza et al.
ANTI-CANCER DRUGS (2016)
Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment
Shanthi Marur et al.
MAYO CLINIC PROCEEDINGS (2016)
The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia
Thomas M. Ashton et al.
NATURE COMMUNICATIONS (2016)
Prognostic Significance of Carbonic Anhydrase IX expression in Cancer Patients: A Meta-Analysis
Simon J. A. van Kuijk et al.
FRONTIERS IN ONCOLOGY (2016)
Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity
Hiroshi Maeda
ADVANCED DRUG DELIVERY REVIEWS (2015)
A Comparison of the Imaging Characteristics and Microregional Distribution of 4 Hypoxia PET Tracers
Sean Carlin et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Hypoxia-targeted radiotherapy dose painting for head and neck cancer using 18F-FMISO PET: A biological modeling study
Joe H. Chang et al.
ACTA ONCOLOGICA (2013)
Accelerated Radiotherapy With Carbogen and Nicotinamide for Laryngeal Cancer: Results of a Phase III Randomized Trial
Geert O. Janssens et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Immuno-imaging using nanobodies
Ilse Vaneycken et al.
CURRENT OPINION IN BIOTECHNOLOGY (2011)
Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging
Ludwig J. Dubois et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck - A systematic review and meta-analysis
Jens Overgaard
RADIOTHERAPY AND ONCOLOGY (2011)
PET of Hypoxia with 89Zr-Labeled cG250-F(ab′)2 in Head and Neck Tumors
Bianca A. W. Hoeben et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Hypoxia in cancer: significance and impact on clinical outcome
Peter Vaupel et al.
CANCER AND METASTASIS REVIEWS (2007)
Share Paper
